Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yuna Wei"'
Autor:
Yujie Chen, Huizhen Jiang, Yuna Wei, Yehan Qiu, Longxiang Su, Jieqing Chen, Xin Ding, Lu Wang, Dandan Ma, Feng Zhang, Wen Zhu, Xiaoyang Meng, Guoqiang Sun, Lian Ma, Yao Wang, Linfeng Li, Guiren Ruan, Fuping Guo, Ting Shu, Xiang Zhou, Bin Du
Publikováno v:
EBioMedicine, Vol 106, Iss , Pp 105257- (2024)
Summary: Background: Sepsis is a leading cause of mortality in intensive care units and vasoactive drugs are widely used in septic patients. The cardiovascular response of septic shock patients during resuscitation therapies and the relationship of t
Externí odkaz:
https://doaj.org/article/5437c7e791fb4a34a06fc70a585d2199
Autor:
Yujie Chen, Yao Wang, Jieqing Chen, Xudong Ma, Longxiang Su, Yuna Wei, Linfeng Li, Dandan Ma, Feng Zhang, Wen Zhu, Xiaoyang Meng, Guoqiang Sun, Lian Ma, Huizhen Jiang, Chang Yin, Taisheng Li, Xiang Zhou
Publikováno v:
Infectious Disease Modelling, Vol 8, Iss 4, Pp 1097-1107 (2023)
Purpose: To establish dynamic prediction models by machine learning using daily multidimensional data for coronavirus disease 2019 (COVID-19) patients. Methods: Hospitalized COVID-19 patients at Peking Union Medical College Hospital from Nov 2nd, 202
Externí odkaz:
https://doaj.org/article/83bb1e9229d249e2b00158ed2c54c9a3
Autor:
Rong Li, Lan Shen, Wenyan Ma, Linfeng Li, Bo Yan, Yuna Wei, Yao Wang, Changqing Pan, Junyi Yuan
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background Radiofrequency ablation (RFA) for atrial fibrillation (AF) is associated with a risk of complications. This study aimed to develop and validate risk models for predicting complications after radiofrequency ablation of atrial fibri
Externí odkaz:
https://doaj.org/article/d9c66a9dc5af42e69f137588ab5b17e4
Autor:
Hairu Huo, Ying Wang, Yaying Zhu, Yuna Wei, Hongmei Li, Jianhui Sun, Lifang Wang, Tan Yuqing, Hu Liufang
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 37
Background and purpose The clinical use of arsenic trioxide (As 2 O 3 ) for treating acute promyelocytic leukemia (APL) is limited due to its severe cardiotoxicity. The possible mechanisms of As 2 O 3 -induced cardiotoxicity include DNA fragmentation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e851abf049ad01facd7c7399fe872ed
https://pubmed.ncbi.nlm.nih.gov/27608960
https://pubmed.ncbi.nlm.nih.gov/27608960